Vaccines for prevention of meningococcal disease

被引：50

作者：

Pollard, AJ ^{[1
]}

Levin, M

机构：

[1] British Columbia Childrens Hosp, BC Res Inst Childrens & Womens Hlth, Div Pediat Infect Dis & Immunol, Vancouver, BC V6H 3V4, Canada

[2] St Marys Hosp, Imperial Coll Sch Med, Dept Paediat, London, England

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2000年 / 19卷 / 04期

关键词：

vaccines; meningococcal disease;

D O I：

10.1097/00006454-200004000-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：333 / 345

页数：13

共 173 条

[1]

Abdillahi H, 1988, FEMS Microbiol Immunol, V1, P139

[2]

ALAALDEEN DAA, 1995, MOL CLIN ASPECTS BAC

[3]

*AM COLL HLTH ASS, 1999, MEN FREQ ASK QUEST

[4] Dynamics of the meningococcal carrier state and characteristics of the carrier strains: a longitudinal study within three cohorts of military recruits [J].

Andersen, J ;

Berthelsen, L ;

Jensen, BB ;

Lind, I .

EPIDEMIOLOGY AND INFECTION, 1998, 121 (01) :85-94

[5] Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development [J].

Andersen, SR ;

Kolberg, J ;

Hoiby, EA ;

Namork, E ;

Caugant, DA ;

Froholm, LO ;

Jantzen, E ;

Bjune, G .

MICROBIAL PATHOGENESIS, 1997, 23 (03) :139-155

[6] SAFETY AND IMMUNOGENICITY OF MENINGOCOCCAL A-POLYSACCHARIDE AND C-POLYSACCHARIDE CONJUGATE VACCINE IN ADULTS [J].

ANDERSON, EL ;

BOWERS, T ;

MINK, CM ;

KENNEDY, DJ ;

BELSHE, RB ;

HARAKEH, H ;

PAIS, L ;

HOLDER, P ;

CARLONE, GM .

INFECTION AND IMMUNITY, 1994, 62 (08) :3391-3395

[7]

[Anonymous], 1995, Commun Dis Rep CDR Rev, V5, pR189

[8]

[Anonymous], 1997, MMWR Recomm Rep, V46, P1

[9]

ARTENSTEIN MS, 1975, J IMMUNOL, V115, P5

[10] IMMUNOGENICITY OF MENINGOCOCCAL-B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID OR CRM197 VIA ADIPIC ACID DIHYDRAZIDE [J].

BARTOLONI, A ;

NORELLI, F ;

CECCARINI, C ;

RAPPUOLI, R ;

COSTANTINO, P .

VACCINE, 1995, 13 (05) :463-470

← 1 2 3 4 5 6 7 8 9 10 →